WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007020259) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID LABILE DRUGS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/020259    International Application No.:    PCT/EP2006/065311
Publication Date: 22.02.2007 International Filing Date: 15.08.2006
IPC:
A61K 9/36 (2006.01), A61K 38/46 (2006.01)
Applicants: SOLVAY PHARMACEUTICALS GMBH [DE/DE]; Hans-boeckler Allee 20, 30173 Hannover (DE) (For All Designated States Except US).
SHLIEOUT, George [DE/DE]; (DE) (For US Only).
KOELLN, Claus-Jürgen [DE/DE]; (DE) (For US Only).
SCZESNY, Frithjof [DE/DE]; (DE) (For US Only).
ONKEN, Jens [DE/DE]; (DE) (For US Only).
KOERNER, Andreas [DE/DE]; (DE) (For US Only)
Inventors: SHLIEOUT, George; (DE).
KOELLN, Claus-Jürgen; (DE).
SCZESNY, Frithjof; (DE).
ONKEN, Jens; (DE).
KOERNER, Andreas; (DE)
Agent: BAURIEGEL, Lutz; Solvay Pharmaceuticals GmbH, c/o Intellectual Property & Scientific Information, Hans-boeckler-allee 20, 30173 Hannover (DE)
Priority Data:
05107472.2 15.08.2005 EP
60/708,692 15.08.2005 US
Title (EN) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID LABILE DRUGS
(FR) COMPOSITIONS PHARMACEUTIQUES A LIBERATION CONTROLEE DESTINEES A DES MEDICAMENTS ACIDO-LABILES
Abstract: front page image
(EN)An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.
(FR)L'invention porte sur une forme posologique orale à enrobage entérosoluble comprenant un ingrédient pharmaceutique actif acido-labile, où la composition est sensiblement exempte d'esters acides phthaliques monomères et d'huiles synthétiques. L'invention porte également sur des méthodes de fabrication et d'utilisation de la forme posologique à enrobage entérosoluble. Lesdites compositions pharmaceutiques renferment un enrobage entérosoluble qui contient au moins un plastifiant, un produit filmogène et éventuellement au moins un agent anticollant.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)